Sputnik V (Gam-COVID-Vac) in COVID-19 prophylaxis (excluding children) - Summary of results Outcome TE 95% CI n k I2 ROB Pub. bias confirmed Covid-19, from 1st dosedetailed results RESIST (Sputnik V Gamaleya Research Institute Russia), 2020 0.27 [0.20; 0.36]
0.27 [0.20 ; 0.36 ] RESIST (Sputnik V Gamaleya Research Institute Russia), 2020 1 0% 21,862 NA not evaluable symptomatic Covid-19detailed results RESIST (Sputnik V Gamaleya Research Institute Russia), 2020 0.08 [0.05; 0.15]
0.08 [0.05 ; 0.15 ] RESIST (Sputnik V Gamaleya Research Institute Russia), 2020 1 0% 19,866 NA not evaluable severe COVID-19 occurrencedetailed results Out of scale RESIST (Sputnik V Gamaleya Research Institute Russia), 2020 0.00 [0.00; NaN]
NaN [NaN ; NaN ] RESIST (Sputnik V Gamaleya Research Institute Russia), 2020 1 0% 19,866 NA not evaluable ATE (Myocardial infarction or ischemic stroke)detailed results RESIST (Sputnik V Gamaleya Research Institute Russia), 2020 0.44 [0.10; 1.97]
0.44 [0.10 ; 1.97 ] RESIST (Sputnik V Gamaleya Research Institute Russia), 2020 1 0% 21,862 NA not evaluable intracranial hemorrhage detailed results RESIST (Sputnik V Gamaleya Research Institute Russia), 2020 0.17 [0.01; 4.93]
0.17 [0.01 ; 4.93 ] RESIST (Sputnik V Gamaleya Research Institute Russia), 2020 1 0% 21,862 NA not evaluable ischemic strokedetailed results RESIST (Sputnik V Gamaleya Research Institute Russia), 2020 1.32 [0.06; 29.35]
1.32 [0.06 ; 29.35 ] RESIST (Sputnik V Gamaleya Research Institute Russia), 2020 1 0% 21,862 NA not evaluable Myocardial infarction detailed results RESIST (Sputnik V Gamaleya Research Institute Russia), 2020 0.66 [0.06; 7.30]
0.66 [0.06 ; 7.30 ] RESIST (Sputnik V Gamaleya Research Institute Russia), 2020 1 0% 21,862 NA not evaluable pulmonary embolismdetailed results RESIST (Sputnik V Gamaleya Research Institute Russia), 2020 0.33 [0.01; 16.68]
0.33 [0.01 ; 16.68 ] RESIST (Sputnik V Gamaleya Research Institute Russia), 2020 1 0% 21,862 NA not evaluable serious adverse events (SAE), anydetailed results RESIST (Sputnik V Gamaleya Research Institute Russia), 2020 1.10 [0.30; 4.01]
1.10 [0.30 ; 4.01 ] RESIST (Sputnik V Gamaleya Research Institute Russia), 2020 1 0% 21,862 NA not evaluable 0.0 2.0 1.0 relative treatment effect www.metaEvidence.org 2024-05-06 01:50 +02:00
TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers);
k: number of studies; n: total number of patients;
ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
